The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Oral Treatment Targeting the Unfolded Protein Response Prevents Neurodegeneration and Clinical Disease in Prion-Infected Mice
Abstract
During prion disease, an increase in misfolded prion protein (PrP) generated by prion replication leads to sustained overactivation of the branch of the unfolded protein response (UPR) that controls the initiation of protein synthesis. This results in persistent repression of translation, resulting in the loss of critical proteins that leads to synaptic failure and neuronal death. We have previously reported that localized genetic manipulation of this pathway rescues shutdown of translation and prevents neurodegeneration in a mouse model of prion disease, suggesting that pharmacological inhibition of this pathway might be of therapeutic benefit. We show that oral treatment with a specific inhibitor of the kinase PERK (protein kinase RNA-like endoplasmic reticulum kinase), a key mediator of this UPR pathway, prevented UPR-mediated translational repression and abrogated development of clinical prion disease in mice, with neuroprotection observed throughout the mouse brain. This was the case for animals treated both at the preclinical stage and also later in disease when behavioral signs had emerged. Critically, the compound acts downstream and independently of the primary pathogenic process of prion replication and is effective despite continuing accumulation of misfolded PrP. These data suggest that PERK, and other members of this pathway, may be new therapeutic targets for developing drugs against prion disease or other neurodegenerative diseases where the UPR has been implicated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In fact, the oral administration of highly selective PERK inhibitors significantly reduces neurodegeneration and clinical disease in prion-infected mice, crossing the BBB efficiently [402,403].”
From GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review (2022) · cites this paper as [402]
Citations
Cites
1 retracted
Atkin, J. D., Farg, M. A., Walker, A. K., McLean, C., Tomas, D., & Horne, M. K. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.02.009 · Cited by 350
RetractedSignal integration in the endoplasmic reticulum unfolded protein response
Ron, D., & Walter, P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2199 · Cited by 6,431
Regulated Translation Initiation Controls Stress-Induced Gene Expression in Mammalian Cells
Harding, H. P., Novoa, I., Zhang, Y., Zeng, H., Wek, R. C., Schapira, M., & Ron, D. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00108-8 · Cited by 3,344
Adapting Proteostasis for Disease Intervention
Balch, W. E., Morimoto, R. I., Dillin, A., & Kelly, J. W. (2008) · Science · doi:10.1126/science.1141448 · Cited by 2,495
Harding, H. P., Zeng, H., Zhang, Y., Jungries, R., Chung, P., Plesken, H., Sabatini, D. D., & Ron, D. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00264-7 · Cited by 1,217
Depleting Neuronal PrP in Prion Infection Prevents Disease and Reverses Spongiosis
Mallucci, G. R., Dickinson, A., Linehan, J. M., Klöhn, P., Brandner, S., & Collinge, J. (2003) · Science · doi:10.1126/science.1090187 · Cited by 783
Self-citationTranslational Regulation of Gene Expression during Conditions of Cell Stress
Spriggs, K. A., Bushell, M., & Willis, A. E. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.028 · Cited by 748
Self-citationAxten, J. M., Medina, J. R., Feng, Y., Shu, A. Y. L., Romeril, S. P., Grant, S. W., Li, W. H. H., Heerding, D. A., Minthorn, E. A., Mencken, T., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300713s · Cited by 620
Self-citationSustained translational repression by eIF2α-P mediates prion neurodegeneration
Moreno, J. A., Radford, H. E., Peretti, D., Steinert, J. R., Verity, N., Martin, M. G., Halliday, M., Morgan, J., Dinsdale, D. D., Ortori, C. A., et al. (2012) · Nature · doi:10.1038/nature11058 · Cited by 616
Self-citationThe Unfolded Protein Response Is Activated in Pretangle Neurons in Alzheimer's Disease Hippocampus
Hoozemans, J. J. M., van Haastert, E. S., Nijholt, D. A. T., Rozemuller, A. J. M., Eikelenboom, P., & Scheper, W. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080814 · Cited by 600
Cited by
Sorted by citations
Items 501–582 of 582
The Integrated Stress Response in Memory and Cognitive Disorders
Mays, J., & Costa‐Mattioli, M. (2020) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780190686307.013.2 · Cited by 1
Yakubu, U. M., Catumbela, C. S. G., Morales, R., & Morano, K. A. (2020) · Open Biology · doi:10.1098/rsob.200282 · Cited by 1
Loeh, B., Korfei, M., Mahavadi, P., Wasnick, R. M., von der Beck, D., & Günther, A. (2016) · European Respiratory Society eBooks · doi:10.1183/2312508x.10004815 · Cited by 1
Broad kinase inhibition mitigates early neuronal dysfunction and cognitive deficits in tauopathyPreprint
Koren, S. A., Hamm, M. J., Cloyd, R., Fontaine, S. N., Chishti, E. A., Lanzillotta, C., Rodriguez-Rivera, J., Ingram, A., Bell, M. C., Escobar, S. M. G., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.31.229583 · Cited by 1
Self-citationBarghout, S. H. (2020) · TSpace (University of Toronto) · doi:10.13140/rg.2.2.10284.90246 · Cited by 1
Bureau, S. C. (2022) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2022-14889 · Cited by 1
Zafar, S., Younas, N., Douet, J., Schmitz, M., Candelise, N., Correia, S., Andréoletti, O., & Zerr, I. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.17.676758 · Cited by 1
Lewis, S. (2013) · Nature reviews. Neuroscience · doi:10.1038/nrn3634
New methods of preventing neurodegeneration? lessons from prion diseases
Beaulieu‐Boire, I., & Fox, S. H. (2013) · Movement Disorders · doi:10.1002/mds.25782
Neuropathogenesis of Prion Disease
Davidson, L., & Knight, R. (2014) · Future Neurology · doi:10.2217/fnl.13.74
Early translational changes in neurons in prion disease
Morgan, J. (2014) · Figshare
Elucidating and Pharmacologically Targeting Secondary Injury Cascades following Neural Injury
Lucke-Wold, B. P. (2016) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.6120
Murphy, P., & Taigman, M. (1998) · PubMed
Zhang, J. (2018) · Focus on structural biology · doi:10.1007/978-981-10-8815-5_14
Investigating the functional roles of microRNA-29b and microRNA-146a in prion diseases
Zhao, W. (2018) · Minerva Access (University of Melbourne)
Boese, A. S., Majer, A., & Booth, S. A. (2018) · Neuromethods · doi:10.1007/978-1-4939-8739-9_14
Lewis, P. A., & Spillane, J. E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811069-0.00004-5
Prion Proteins and Neuronal Death in the Cerebellum
Ragagnin, A., Wang, Q., Guillemain, A., Dole, S., Wilding, A.-S., Demais, V., Royer, C., Haeberlé, A., Vitale, N., Gasman, S., et al. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.80701
eIF2B bodies and their role in the integrated stress response
Hodgson, R. E. (2019) · Sheffield Hallam University · doi:10.7190/shu-thesis-00240
Tabbarah, S. (2018) · TSpace (University of Toronto)
Viral evasion of cellular stress responses
Rabouw, H. H. (2020) · doi:10.33540/217
Novel Approaches to Fight Prion Diseases
Thapa, S. (2020) · doi:10.11575/prism/37788
Sreedharan, J., & Brown, R. H. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-410529-4.00087-5
de Grey, A. D. N. J., & Rae, M. J. (2019) · Springer eBooks · doi:10.1007/978-3-319-69892-2_436-1
Gong, J. (2020) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8039
Elucidating Mechanisms of Neurobehavioral Dysfunction in a Rodent Model of Traumatic Brain Injury
Logsdon, A. F. (2016) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.6106
Experimental investigation on cold trap regeneration of FBR IHTS
Ohshima, I., Mukai, K., Hiromichi, N. E. I., Ohtani, R., & Terasawa, M. (1982) · Transactions of the American Nuclear Society
Proteostasis impairment and ER stress as a possible target to treat Parkinson's disease
Martinez, A. N., Černá, M., Gozalvo, R., & Hetz, C. A. (2021) · International review of movement disorders · doi:10.1016/bs.irmvd.2021.09.002
Sims, S. G. (2021) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.10189
de Grey, A. D. N. J., & Rae, M. J. (2021) · Springer eBooks · doi:10.1007/978-3-030-22009-9_436
Sigurdson, C. J., Kim, M., & Geschwind, M. D. (2016) · ASM Press eBooks · doi:10.1128/9781555819439.ch59
Diamond, B. J., & Kolak, J. (2018) · Springer eBooks · doi:10.1007/978-3-319-57111-9_562
de Grey, A. D. N. J., & Rae, M. J. (2021) · Springer eBooks · doi:10.1007/978-3-319-69892-2_436-2
Diamond, B. J., & Kolak, J. (2017) · Springer eBooks · doi:10.1007/978-3-319-56782-2_562-4
Briggs, M. D. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733669789.793573481
Diehl, J. A. (2017) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727294526.793538085
PLoS Pathogens Issue Image | Vol. 10(12) December 2014
(2014) · PLoS Pathogens · doi:10.1371/image.ppat.v10.i12
Molecular Insights into the Role of ER Stress in Neurodegenerative Diseases
Kabir, M. T. (2022) · Springer eBooks · doi:10.1007/978-981-16-7606-2_9
Cannabidiol and Trazodone Ameliorate Neuronal Proteotoxicity in C. elegansPreprint
Gilberto, V. S., McGrath, S., Alsulami, A., Vidrio-Aguirre, A., & Moreno, J. A. (2022) · Research Square · doi:10.21203/rs.3.rs-2351138/v1
Self-citationTransgenic Mice Modelling in Prion Diseases
Bradford, B. M., Mabbott, N. A., & Diack, A. B. (2023) · Springer eBooks · doi:10.1007/978-3-031-20565-1_15
Neuron-specific resilience to proteostatic stress
Wolzak, K. (2023) · doi:10.5463/thesis.349
Update on the pathophysiology of prion diseases
Mallucci, G. R., & Verity, N. (2014) · Advances in Clinical Neuroscience & Rehabilitation · doi:10.47795/gzat8254
Self-citationZHU, D., Liu, G., FENG, K., Li, S., Hu, D., Yang, S., & Li, P. (2024) · Biocell · doi:10.32604/biocell.2024.044856
A Community Program “Eat Well, See Clearly” For Early Detection Of Diabetic Retinopathy
Sheiladevi, S., Yu, J., Law, Y., Prakash, S., & Dar, H. T. (2024) · doi:10.53555//kuey.v30i6.3066
Britt, W. J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-82763-8.00211-9
Maladies à prions ou encéphalopathies spongiformes transmissibles
Brandel, J., & Haı̈k, S. (2025) · Encyclopédie médico-chirurgicale. Neurologie · doi:10.1016/s0246-0378(25)44895-7
Mitochondrial Dysfunction, Endoplasmic Reticulum Stress, and Their Role in Neurodegeneration
Shamnewadi, A., Patil, V. S., & Jalalpure, S. S. (2025) · Springer eBooks · doi:10.1007/978-981-95-3945-1_4
Exploring the Role of Nutraceuticals in Brain Cancer Prevention and Treatment
Mandoth, V. V., Ravindranath, B. S., & Hema Kumar, C. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898811747125010010
Stem Cell Therapy for Neurological Disorders: From Bench to Bedside
Barbuti, P. A. (2014) · Springer eBooks · doi:10.1007/978-81-322-2110-4_4
Malattie da prioni o encefalopatie spongiformi trasmissibili
Brandel, J., & Haı̈k, S. (2026) · EMC - Neurologia · doi:10.1016/s1634-7072(25)51362-4
Proteostasis disruption under hypoxia: therapeutic targets in cancer and neurodegenerative diseases
Rahmiyati, S., Prijanti, A. R., Jusman, S. W. A., & Dewi, S. (2025) · Acta Biochimica Indonesiana · doi:10.32889/actabioina.142
Almeida, L. M., Lima, L. P., Oliveira, N. A. S., Silva, R. F. O., Sousa, B., Bessa, J., Pinho, B. R., & Oliveira, J. M. A. (2026) · Pharmacological Reports · doi:10.1007/s43440-026-00837-7
Alexopoulos, H., Samiotaki, M. K., Gkogkou, E., Mavromati, S., Bitzogli, K., Panagiotou, G., Tzioufas, A. G., Magira, E. E., Kotanidou, Α., & Trougakos, I. P. (2026) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.70042
Maladies à prions : vers le développement d'une thérapie génique et cellulaire
Souder, C. L. (2017) · theses.fr (ABES) · doi:10.70675/2b878862z67daz4e3azab26z026e8344ce30
Physiopathologie et thérapeutique des prions humains : une approche cellulaire
Gougerot, A. (2017) · theses.fr (ABES) · doi:10.70675/847a4bffz5694z406bzb408z6f67f4245892
Boudet-Devaud, F. (2018) · theses.fr (ABES) · doi:10.70675/111341b9z5eeez4531z8f07zcb44d6f469a0
Targeting IRE1 activity in Glioblastoma Multiforme
Doultsinos, D. (2019) · theses.fr (ABES) · doi:10.70675/144ae2a8z9211z4b25za8aeza4d20ed0eafd
Fine-tuning UPR signals and subsequent cellular outputs
Papaioannou, A. (2019) · theses.fr (ABES) · doi:10.70675/50aa6a06zc458z48e5z9416z7682f49fb7f3
Arnould, H. (2019) · theses.fr (ABES) · doi:10.70675/9f070729z72aez4fccz9604z8c52be1a62e6
Ribeiro, L. W. (2023) · theses.fr (ABES) · doi:10.70675/68582d99z4406z4ad4zbd76z15927fb63da5
Theory and simulations of delayed stochastic and deterministic models of prion diseases
Boregowda, G., Sharif, O., Gutierrez, D., III, Simmons, A., Pujo-Menjouet, L., Oraby, T., & Lindstrom, M. R. (2026) · Journal of Mathematical Biology · doi:10.1007/s00285-026-02390-6
Owolabi, T. A., Adeyemi, S. A., & Choonara, Y. E. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33623-2.00010-6
Role of endoplasmic reticulum stress in angiogenesis
Bhardwaj, S., Reyaz, H., & Jain, B. P. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-41553-1.00002-5
Using human 3D organoid models to gain mechanistic insight in motor neuron diseases
Frizzi, B., Correia, A. M. B., Faravelli, I., Bosch, L. V. D., & Corti, S. P. (2026) · Nature reviews. Neuroscience · doi:10.1038/s41583-026-01057-x
LRRK2 and Nrf2 regulation in Parkinson’s disease: Mechanistic insights and therapeutic potential
Sunkersett, E., Kumar, D., Kumar, K., & Prajapati, V. K. (2026) · Advances in pharmacology · doi:10.1016/bs.apha.2026.07.003
Torres, P., Becerra, D., Astorga, J. I., Fuentealba, M., Kauwe, G., Gonzalez, L., Diaz, G., Morales, V., Valenzuela, V., Wehrfritz, C., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.07.743573
Huang, Y., Zeng, Y., Zhong, X., & Li, L. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1855305
DNL343 and Disease Progression in Amyotrophic Lateral Sclerosis
Paganoni, S., Chibnik, L. B., Quintana, M., Macklin, E. A., Detry, M. A., Vestrucci, M., Paulon, G., McGlothlin, A., Wang, J., Walk, D., et al. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2026.34809
Genetic variation in Eif2ak3 alters astrocyte-dependent stress tolerance in neuronsPreprint
Ghura, S., Alvarez-Periel, E., Newton, S. E. B., Akay, C., & Jordan‐Sciutto, K. L. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.29.755429
Proteostasis collapse and unfolded protein response-mediated neurodegeneration in prion disease
Syeda, A., Nafiz, M., & Ubaid-ullah, S. (2026) · Frontiers in Cell Death · doi:10.3389/fceld.2026.1941546
BindingDB (2020) · UC San Diego · doi:10.7270/q24170kg
Neuroprotectant development from small molecule inhibitors of CHOP/ATF4 expression
Mu, L., Yan, X., Yang, H., Liu, L., Feng, X., Bian, F., Huang, H., Dalal, R., Solow-Cordero, D. E., Schow, S., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.118225
Bizingre, C., Picard, F., Roussel, F. S., Bianchi, C., Alleaume‐Butaux, A., Chevé, M., Ardila-Osorio, H., Pietri, M., Lavieu, G., Baudry, A., et al. (2026) · Journal of Extracellular Biology · doi:10.1002/jex2.70195
Metadata
- Authors
- Moreno, J. A., Halliday, M., Molloy, C., Radford, H., Verity, N., Axten, J. M., Ortori, C. A., Willis, A. E., Fischer, P. M., Barrett, D. A., & Mallucci, G. R.
- Affiliations
- University of Leicester (GB)
- GlaxoSmithKline (United States) (US)
- University of Nottingham (GB)
- Corresponding author
- Mallucci, Giovanna R.
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2013-10-09
- Volume
- 5
- Issue
- 206
- Pages
- 206ra138-206ra138
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2010375635
- Cited by
- 589
- References
- 29
- Citations by year
- 2026: 22 · 2025: 27 · 2024: 21 · 2023: 29 · 2022: 32 · 2021: 42 · 2020: 59 · 2019: 46 · 2018: 54 · 2017: 72 · 2016: 54 · 2015: 58 · 2014: 58 · 2013: 13
- FWCI
- 27.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Leicester Research Archive (University of Leicester) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- prion disease, unfolded protein response, protein synthesis inhibition, neurodegeneration, oral drug therapy, neuroprotection, prion replication, synaptic failure, neurodegenerative disease treatment
- MeSH terms
- Adenine, Administration, Oral, Animals, Blood-Brain Barrier, Brain, Indoles, Nerve Degeneration, Phosphorylation, Prions, Synapses, Protein Biosynthesis, Eukaryotic Initiation Factor-2, Prion Diseases, Neuroprotective Agents, eIF-2 Kinase, Mice, Unfolded Protein Response
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review